Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
暂无分享,去创建一个
N. Saijo | Y. Nishiwaki | Y. Ohe | K. Kubota | N. Yamamoto | T. Tamura | H. Kunitoh | N. Yamamoto | H. Nokihara | T. Kato | I. Sekine | Y. Ohe | T. Kato | T. Tamura